Clinical trials sponsored by Seoul National University Bundang Hospital
12
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 3 1Phase 4 6Not applicable 5
Conditions studied
Recruiting trials led by Seoul National University Bundang Hospital
- Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
- Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
- Clopidogrel Versus Cilostazol on Vessels
- Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled Trial
- Dual-chamber Patient-controlled Analgesia for Postoperative Recovery
- Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
- Korean Heart Failure Registry III
- Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
- Predictors of Prognosis in IBD Patients
- Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions
- SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection
- The EMPA-FIT Study
Common questions
How many trials is Seoul National University Bundang Hospital recruiting for?
Seoul National University Bundang Hospital is the lead sponsor of 12 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.